Authors


Paris Adkins-Jackson, PhD

Latest:

Clinical Trials and Trust

Understanding the role of social determinants on clinical trial participation and trust.


Jayathirtha Gopalakrishna

Latest:

Establishing Metrics and Standardization for Non-CRF Data in EDC

While Case Report Forms are a main contributor to collected data, non-CRF data such as core laboratory data and central imaging can be critical to any clinical study.



Dale Hanna

Latest:

Direct-to-Patient: At-Home Clinical Trials Are Here to Stay

The success of the decentralized model hinges on coordination between stakeholders across the supply chain to ensure that date is secure, medication is delivered on time, and in proper condition.


Kristy Birchard

Latest:

Prioritizing Patients: Strategies and eCOA Best Practices in Drug Development

A more user-centered design can allow increased flexibility in the development of eCOA platforms, driving better engagement and participation.


Christoph Koenen

Latest:

Changing the Digital Health Playing Field: A New Era

Moving beyond the pill to extend the value being delivered to patients.



Florence Mowlem, PhD

Latest:

Navigating the Intersection of Accessibility and Measurement Integrity in eCOA

Clinical research evolves to prioritize patient-centered outcomes, integrating accessibility standards in electronic data capture for inclusive clinical trials.


JP Kappelle

Latest:

Increased Digitization in Clinical Trials: Expectations for the Year Ahead

Top predictions for the major trends that will shape clinical trial design in 2022.


Stacy Hurt

Latest:

Tapping the Patient Voice as a Strategic Differentiator

The future of clinical trial design involves incorporating the patient experience into strategic asset planning.


Emily Mitchell

Latest:

Early Protocol Assessment for Increased Patient Centricity

How novel clinical trial designs can help minimize patient burden.


Daniella Tinoco, PhD and Christine Moore, PhD

Latest:

The Value of Clinical Trial Liaisons in the Drug Development Lifecycle

Clinical trial liaisons rather serve as experts in their therapeutic areas and as clinical trial specialists to provide a suite of strategic advantages to benefit a study.


Gabriel Maeztu

Latest:

Harnessing Unstructured Data and Hospital Interoperability

The potential of next-generation platforms in transforming patient recruitment.


Kimberly Wanick

Latest:

Compliance Amid the ‘Great Resignation’

Minimizing impacts through focus on employee wellness.


Amy McKee, M.D., Chief Medical Officer and Global Head, Oncology Center of Excellence, Parexel

Latest:

Four Key Trends for Identifying Regulator and Payer Evidence Needs in Oncology Drug Development

How to leverage novel trial designs and real-world data to support a cancer drug submission with an evidence strategy that is both approvable and reimbursable.



Svyatoslav Sergeevich Milovanov

Latest:

Rate of Patient Recruitment to International Multicenter Clinical Studies in Eastern Europe Countries

The success of a clinical study depends on the possibilities to involve the patient in the study.


Carrie Northcott, PhD

Latest:

Digital Measures of Health: What’s in it for Patients?

Exploring the different stages in the development of a digital measure, and the activities and steps key to achieving meaningful impact for patients.


Krishnan Rajagopalan, PhD

Latest:

Getting the Most From FSP Model

Examining best practices in using the functional service provider model for clinical operations, pharmacovigilance, regulatory, and other areas.


Stella Sechopoulos

Latest:

Getting to Clinical Trial Diversity

Differing levels of trust in clinical trials information channels across diverse populations is examined in this research.



Michael Clay

Latest:

Currency of Patient Engagement: Changing Tides

Meeting patients at the point of care can increase trust and engagement.


Diana Foster, PhD

Latest:

Identify Opportunities to Improve Diversity Recruitment

While it's important to note that there are areas where the industry can improve, there are unique opportunities of improvement for specific types of sites and the number of studies conducted there.



Ben James

Latest:

Engaging Patients With Behavioral Science and Patient-centered Technology

Evolving mindsets are opening the door for industry to utilize new mediums for understanding patients.



Jim DiCesare

Latest:

Why Sponsors Should Consider a Hybrid Approach for Clinical Trial Payments

Bringing some payment activities in-house while outsourcing others can help sponsors optimize clinical trial efficiency, reduce risks, and strengthen site relationships.


Todd Rudo, MD

Latest:

The Future Fit of Wearables for Patient-Centric Clinical Trials

Harnessing these tools for successful integration and streamlining of processes.


Mary Gunn, PhD, MBA

Latest:

Clinical Trials as a Competitive Edge: Strategic Considerations

Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.


Salman Shah

Latest:

The Power of Automation

Becoming a preferred pharma partner for clinical trial sites.

© 2025 MJH Life Sciences

All rights reserved.